Portal de Periódicos da CAPES

Third Chinese National Consensus Report on the management of Helicobacter pylori infection 1 (August 2007, Lushan, Jiangxi Province, China)

2008; Wiley; Volume: 9; Issue: 3 Linguagem: Inglês

10.1111/j.1751-2980.2008.00342.x

1751-2980

Wen Zhong Liu, Yong Xie, Hong Cheng, Nong Hua Lu, Fu Hu, Wan Dai Zhang, Li Zhou, Ye Chen, Zhi Zeng, Chong Wen Wang, Shu Dong XIAO, Guo Zong Pan, Pin Jin Hu,

Gastroesophageal reflux and treatments

Journal of Digestive DiseasesVolume 9, Issue 3 p. 178-184 Third Chinese National Consensus Report on the management of Helicobacter pylori infection1(August 2007, Lushan, Jiangxi Province, China) Fu Lian HU, Fu Lian HU Department of Gastroenterology, First Hospital Peking University, BeijingSearch for more papers by this authorPin Jin HU, Pin Jin HU Department of Gastroenterology, First Affiliated Hospital, Sun Yat-Sen University, GuangzhouSearch for more papers by this authorWen Zhong LIU, Wen Zhong LIU Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, ShanghaiSearch for more papers by this authorJi De WANG, Ji De WANG Department of Gastroenterology, Nanfang Hospital, Southern Medical University, GuangzhouSearch for more papers by this authorNong Hua LV, Nong Hua LV Department of Gastroenterology, First Affiliated Hospital, Nanchang University, Nanchang, ChinaSearch for more papers by this authorShu Dong XIAO, Shu Dong XIAO Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, ShanghaiSearch for more papers by this authorWan Dai ZHANG, Wan Dai ZHANG Department of Gastroenterology, Nanfang Hospital, Southern Medical University, GuangzhouSearch for more papers by this authorHong CHENG, Hong CHENG Department of Gastroenterology, First Hospital Peking University, BeijingSearch for more papers by this authorYong XIE, Yong XIE Department of Gastroenterology, First Affiliated Hospital, Nanchang University, Nanchang, ChinaSearch for more papers by this author Fu Lian HU, Fu Lian HU Department of Gastroenterology, First Hospital Peking University, BeijingSearch for more papers by this authorPin Jin HU, Pin Jin HU Department of Gastroenterology, First Affiliated Hospital, Sun Yat-Sen University, GuangzhouSearch for more papers by this authorWen Zhong LIU, Wen Zhong LIU Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, ShanghaiSearch for more papers by this authorJi De WANG, Ji De WANG Department of Gastroenterology, Nanfang Hospital, Southern Medical University, GuangzhouSearch for more papers by this authorNong Hua LV, Nong Hua LV Department of Gastroenterology, First Affiliated Hospital, Nanchang University, Nanchang, ChinaSearch for more papers by this authorShu Dong XIAO, Shu Dong XIAO Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, ShanghaiSearch for more papers by this authorWan Dai ZHANG, Wan Dai ZHANG Department of Gastroenterology, Nanfang Hospital, Southern Medical University, GuangzhouSearch for more papers by this authorHong CHENG, Hong CHENG Department of Gastroenterology, First Hospital Peking University, BeijingSearch for more papers by this authorYong XIE, Yong XIE Department of Gastroenterology, First Affiliated Hospital, Nanchang University, Nanchang, ChinaSearch for more papers by this author First published: 18 July 2008 https://doi.org/10.1111/j.1751-2980.2008.00342.xCitations: 17 Correspondence to: Fu Lian HU, Department of Gastroenterology, First Hospital Peking University, Beijing, China. Email: [email protected] 1 The Chinese National Consensus Workshop on Helicobacter pylori infection was organized by the Helicobacter pylori Infection Study Group, Chinese Society of Gastroenterology, Chinese Medical Association Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Chinese Society of Gastroenterology. Chinese consensus on chronic gastritis. Chin J Gastroenterol 2006; 11: 674–84 (in Chinese). 2 Malfertheiner P, Megraud F, O'Morain C et al . Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772–81. 3 Moayyedi P, Deeks J, Talley NJ et al . An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003; 98: 2621–6. 4 Talley NJ, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129: 1756–80. 5 Hunt RH, Xiao SD, Megraud F et al . World Gastroenterology Organization (WGO-OMGE) practice guideline: Helicobacter pylori in developing countries. Chin J Gastroenterol 2007; 12: 40–52 (in Chinese). 6 Madisch A, Miehlke S, Neuber F et al . Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double-blind, placebo-controlled multicentre trial. Aliment Pharmacol Ther 2006; 23: 473–9. 7 Haruma K, Kamada T, Sugiu K et al . Gastric hyperplastic polyp is one of the diseases for which H. pylori eradication is recommended. Nippon Rinsho 2005; 63 (Suppl 11): 285–7. 8 Santolaria Piedrafita S, Conde Garc¨a R, Abascal Agorreta M et al . Resolution of Ménétrier's disease after eradication of Helicobacter pylori infection. Gastroenterol Hepatol 2004; 27: 357–61 (in Spanish). 9 Jung JH, Hong SJ, Lee MS. Resolution of Ménétrier's disease after Helicobacter pylori eradication. Korean J Gastroenterol 2006; 48: 1–3 (in Korean). 10 Di Vita G, Patti R, Aragona F et al . Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. Dig Dis 2001; 19: 179–83. 11 Gatta L, Vakil N, Ricci C et al . Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol 2004; 99: 823–9. 12 Bravo LE, Realpe JL, Campo C et al . Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 2380–3. 13 Laheij RJ, Straatman H, Jansen JB et al . Evaluation of commercially available Helicobacter pylori serology kits: a review. J Clin Microbiol 1998; 36: 2803–39. 14 Bourke B, Ceponis P, Chiba N et al . Canadian Helicobacter Study Group Consensus Conference: update on the approach to Helicobacter pylori infection in children and adolescents – an evidence-based evaluation. Can J Gastroenterol 2005; 19: 399–408. 15 Kokkola A, Rautelin H, Puolakkainen P et al . Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000; 35: 138–41. 16 Lehours P, Ruskone-Fourmestraux A, Lavergne A et al . Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma? Am J Gastroenterol 2003; 98: 291–5. 17 Schilling D, Demel A, Adamek HE et al . A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. Dig Liver Dis 2003; 35: 217–21. 18 Wang J-Q, Chen Y, Xu K-Q et al . Evaluation of the accuracy of several methods in detecting Helicobacter pylori infection. Chin J Dig Endoscopy 2000; 17: 248–9 (in Chinese). 19 Chinese Society of Gastroenterology and Chinese Medical Association. Consensus on the management of Helicobacter pylori infection. Tocheng, Anhui Province, 2003. Chin J Dig Dis 2004; 5: 186–8. 20 Cheng H, Wei H, Hu F-L. Comparison of ranitidine bismuth citrate and lansoprazole-based regimens in the treatment of Helicobacter pylori infection. Chin New Drugs J 2004; 13: 441–4 (in Chinese). 21 Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 2007; 26: 343–57. 22 Mu FH, Hu FL, Yang G et al . A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for Helicobacter pylori eradication. Chin J Gastroenterol 2007; 12: 531–4 (in Chinese). 23 Mégraud F. Update on therapeutic options for Helicobacter pylori-related diseases. Curr Infect Dis Rep 2005; 7: 115–20. 24 Cheng H, Hu F, Xie Y et al . Prevalence of Helicobacter pylori resistance to antibiotics and its influence on the treatment outcome in China: a multicenter clinical study. Chin J Gastroenterol 2007; 12: 525–30 (in Chinese). 25 Wong WM, Wong BC, Lu H et al . One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. Aliment Pharmacol Ther 2002; 16: 793–8. 26 Gisbert JP, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35–44. 27 Saad RJ, Schoenfeld P, Kim HM et al . Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 2006; 101: 488–96. 28 Nista EC, Candelli M, Zocco MA et al . Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 21: 1241–7. 29 Uygun A, Ozel AM, Yildiz O et al . Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy. J Gastroenterol Hepatol 2008; 23: 42–5. 30 Rodgers C, Van Zanten SV. A meta-analysis of the success rate of Helicobacter pylori therapy in Canada. Can J Gastroenterol 2007; 21: 295–300. 31 Treiber G, Ammon S, Malfertheiner P et al . Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures. Helicobacter 2002; 7: 225–31. 32 Daghaghzadeh H, Emami MH, Karimi S et al . One-week versus two-week furazolidone-based quadruple therapy as the first-line treatment for Helicobacter pylori infection in Iran. J Gastroenterol Hepatol 2007; 22: 1399–403. 33 Nijevitch AA, Shcherbakov PL, Sataev VU et al . Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone. Aliment Pharmacol Ther 2005; 22: 881–7. 34 Fakheri H, Merat S, Hosseini V et al . Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther 2004; 19: 89–93. 35 Gisbert JP, Gisbert JL, Marcos S et al . Levofloxacin vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Helicobacter 2007; 12: 68–73. 36 Gisbert JP, Gisbert JL, Marcos S et al . Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther 2006; 24: 1469–74. 37 Cheon JH, Kim N, Lee DH et al . Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. Helicobacter 2006; 11: 46–51. 38 Ford A, Moayyedi P. How can the current strategies for Helicobacter pylori eradication therapy be improved? Can J Gastroenterol 2003; 17 (Suppl B): 36B–40B. 39 Toracchio S, Cellini L, Di Campli E et al . Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 1639–43. 40 Zullo A, Gatta L, De Francesco V et al . High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther 2005; 21: 1419–24. 41 Francavilla R, Lionetti E, Castellaneta SP et al . Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005; 129: 1414–19. 42 Scaccianoce G, Hassan C, Panarese A et al . Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Can J Gastroenterol 2006; 20: 113–17. 43 Bago P, Vcev A, Tomic M et al . High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. Wien Klin Wochenschr 2007; 119: 372–8. Citing Literature Volume9, Issue3August 2008Pages 178-184 ReferencesRelatedInformation